Annual Current Liabilities
$37.01 M
+$1.91 M+5.45%
December 31, 2023
Summary
- As of February 7, 2025, VERV annual total current liabilities is $37.01 million, with the most recent change of +$1.91 million (+5.45%) on December 31, 2023.
- During the last 3 years, VERV annual current liabilities has risen by +$29.69 million (+405.89%).
- VERV annual current liabilities is now at all-time high.
Performance
VERV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$42.64 M
+$2.27 M+5.64%
September 30, 2024
Summary
- As of February 7, 2025, VERV quarterly total current liabilities is $42.64 million, with the most recent change of +$2.27 million (+5.64%) on September 30, 2024.
- Over the past year, VERV quarterly current liabilities has increased by +$8.07 million (+23.33%).
- VERV quarterly current liabilities is now at all-time high.
Performance
VERV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VERV Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | +23.3% |
| 3 y3 years | +405.9% | +23.3% |
| 5 y5 years | +941.5% | +23.3% |
VERV Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.0% | at high | +188.1% |
| 5 y | 5-year | at high | +941.5% | at high | +538.0% |
| alltime | all time | at high | +941.5% | at high | +538.0% |
Verve Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $42.64 M(+5.6%) |
| Jun 2024 | - | $40.37 M(+29.0%) |
| Mar 2024 | - | $31.29 M(-15.4%) |
| Dec 2023 | $37.01 M(+5.4%) | $37.01 M(+7.0%) |
| Sep 2023 | - | $34.58 M(+4.7%) |
| Jun 2023 | - | $33.03 M(-1.6%) |
| Mar 2023 | - | $33.55 M(-4.4%) |
| Dec 2022 | $35.09 M | $35.09 M(+20.9%) |
| Sep 2022 | - | $29.02 M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $25.85 M(+74.6%) |
| Mar 2022 | - | $14.80 M(-32.8%) |
| Dec 2021 | $22.02 M(+201.1%) | $22.02 M(+8.8%) |
| Sep 2021 | - | $20.25 M(+134.1%) |
| Jun 2021 | - | $8.65 M(+29.4%) |
| Mar 2021 | - | $6.68 M(-8.6%) |
| Dec 2020 | $7.32 M(+105.9%) | - |
| Dec 2020 | - | $7.32 M |
| Dec 2019 | $3.55 M | - |
FAQ
- What is Verve Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Verve Therapeutics?
- What is Verve Therapeutics annual current liabilities year-on-year change?
- What is Verve Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Verve Therapeutics?
- What is Verve Therapeutics quarterly current liabilities year-on-year change?
What is Verve Therapeutics annual total current liabilities?
The current annual current liabilities of VERV is $37.01 M
What is the all time high annual current liabilities for Verve Therapeutics?
Verve Therapeutics all-time high annual total current liabilities is $37.01 M
What is Verve Therapeutics annual current liabilities year-on-year change?
Over the past year, VERV annual total current liabilities has changed by +$1.91 M (+5.45%)
What is Verve Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VERV is $42.64 M
What is the all time high quarterly current liabilities for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total current liabilities is $42.64 M
What is Verve Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VERV quarterly total current liabilities has changed by +$8.07 M (+23.33%)